Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia

by Davidson, Michael H.
Published in EBioMedicine (2015)

Intensive statin therapy in India: Demonstrating efficacy and safety

by Davidson, Michael H.
Published in Indian Heart J (2016)

Apolipoprotein Measurements: Is More Widespread Use Clinically Indicated?

by Davidson, Michael H.
Published in Clin Cardiol (2009)

Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia

by Benes, Lane B, Bassi, Nikhil S, Davidson, Michael H
Published in Vasc Health Risk Manag (2016)

A comparison of Canadian and American guidelines for lipid management using data from the National Cholesterol Education Program Evaluation ProjecT Utilizing Novel E-technology (NE...

by Maki, Kevin C, Davidson, Michael H, Dicklin, Mary R
Published 2006

Cardiorenal Safety of OTC Analgesics

by White, William B., Kloner, Robert A., Angiolillo, Dominick J., Davidson, Michael H.
Published in J Cardiovasc Pharmacol Ther (2018)

Pioglitazone-Mediated Changes in Lipoprotein Particle Composition Are Predicted by Changes in Adiponectin Level in Type 2 Diabetes

by Sam, Susan, Haffner, Steven, Davidson, Michael H., D'Agostino, Ralph, Perez, Alfonso, Mazzone, Theodore
Published 2012

ω-6 Polyunsaturated Fatty Acids and Cardiometabolic Health: Current Evidence, Controversies, and Research Gaps

by Maki, Kevin C, Eren, Fulya, Cassens, Martha E, Dicklin, Mary R, Davidson, Michael H
Published in Adv Nutr (2018)

Pioglitazone vs. Glimepiride on Coronary Artery Calcium Progression in Type 2 Diabetes: A Secondary Endpoint of the CHICAGO Study

by Davidson, Michael H., Beam, Craig A., Haffner, Steven, Perez, Alfonso, D’Agostino, Ralph, Mazzone, Theodore
Published 2010

Indicators of the atherogenic lipoprotein phenotype measured with density gradient ultracentrifugation predict changes in carotid intima-media thickness in men and women

by Maki, Kevin C, Dicklin, Mary R, Davidson, Michael H, Mize, Patrick D, Kulkarni, Krishnaji R
Published 2012

Ethnic Differences in Achievement of Cholesterol Treatment Goals: Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II

by Clark, Luther T, Maki, Kevin C, Galant, Ron, Maron, David J, Pearson, Thomas A, Davidson, Michael H
Published 2006

Time-related trends in variability of cIMT changes in statin trials

by Davidson, Michael H., Tomassini, Joanne E., Jensen, Erin, Neff, David, Polis, Adam B., Tershakovec, Andrew M.
Published in Data Brief (2015)

Effects of fenofibrate on atherogenic dyslipidemia in hypertriglyceridemic subjects

by Davidson, Michael H., Bays, Harold E., Stein, Evan, Maki, Kevin C., Shalwitz, Robert A., Doyle, Ralph
Published in Clin Cardiol (2006)

Relationship of Abdominal Visceral and Subcutaneous Adipose Tissue With Lipoprotein Particle Number and Size in Type 2 Diabetes

by Sam, Susan, Haffner, Steven, Davidson, Michael H., D'Agostino, Ralph B., Feinstein, Steven, Kondos, George, Perez, Alfonso, Mazzone, Theodore
Published 2008

Relation of Abdominal Fat Depots to Systemic Markers of Inflammation in Type 2 Diabetes

by Sam, Susan, Haffner, Steven, Davidson, Michael H., D'Agostino, Ralph B., Feinstein, Steven, Kondos, George, Perez, Alfonso, Mazzone, Theodore
Published 2009

Hypertriglyceridemic Waist Phenotype Predicts Increased Visceral Fat in Subjects With Type 2 Diabetes

by Sam, Susan, Haffner, Steven, Davidson, Michael H., D'Agostino, Ralph B., Feinstein, Steven, Kondos, George, Perez, Alfonso, Mazzone, Theodore
Published 2009

Development and Content Validity of the Statin Experience Assessment Questionnaire (SEAQ)©

by Jacobson, Terry A., Edelman, Steven V., Galipeau, Nina, Shields, Alan L., Mallya, Usha G., Koren, Andrew, Davidson, Michael H.
Published in Patient (2016)

Low‐dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low‐density lipoprotein cholesterol in patients with primary hypercholesterolemia...

by Davidson, Michael H., Toth, Phillip, Weiss, Stuart, Mckenney, James, Hunninghake, Donald, Isaacsohn, Jonathan, Donovan, Joanne M., Burke, Steven K.
Published in Clin Cardiol (2009)

Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control

by Ray, Kausik K., Ginsberg, Henry N., Davidson, Michael H., Pordy, Robert, Bessac, Laurence, Minini, Pascal, Eckel, Robert H., Cannon, Christopher P.
Published in Circulation (2016)

Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

by Pergola, Pablo E., Devalaraja, Matt, Fishbane, Steven, Chonchol, Michel, Mathur, Vandana S., Smith, Mark T., Lo, Larry, Herzog, Kurt, Kakkar, Rahul, Davidson, Michael H.
Published in J Am Soc Nephrol (2021)